This is an open-label clinical trial to investigate a combination therapy for treating
gastrointestinal problems in children with autism spectrum disorders.
The combination therapy includes beneficial bacteria.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Arizona State University
Collaborators:
Northern Arizona University University of Arizona University of Minnesota University of Minnesota - Clinical and Translational Science Institute